Atezolizumab-induced encephalitis in metastatic lung cancer: a case report and literature review.
作者信息
Arakawa Masafumi, Yamazaki Mineo, Toda Yusuke, Saito Riho, Ozawa Akiko, Kosaihira Seiji, Kimura Kazumi
机构信息
Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku 113-8603, Tokyo, Japan.
出版信息
eNeurologicalSci. 2018 Dec 17;14:49-50. doi: 10.1016/j.ensci.2018.12.001. eCollection 2019 Mar.
Abstract
摘要
相似文献
1
Atezolizumab-induced encephalitis in metastatic lung cancer: a case report and literature review.阿替利珠单抗诱发的转移性肺癌脑炎：一例报告及文献综述
eNeurologicalSci. 2018 Dec 17;14:49-50. doi: 10.1016/j.ensci.2018.12.001. eCollection 2019 Mar.
2
Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature.阿替利珠单抗诱发的转移性膀胱癌脑炎：一例报告及文献复习
Clin Genitourin Cancer. 2017 Oct;15(5):e847-e849. doi: 10.1016/j.clgc.2017.03.001. Epub 2017 Mar 16.
3
Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature.重症监护病房中与阿替利珠单抗相关的脑炎：病例报告及文献综述
SAGE Open Med Case Rep. 2018 Aug 2;6:2050313X18792422. doi: 10.1177/2050313X18792422. eCollection 2018.
4
Fatal outcome of atezolizumab in a patient with immune-mediated pneumonitis, thrombocytopenia, and cardiac dysfunction: A case report
.阿特珠单抗治疗一名伴有免疫介导性肺炎、血小板减少症和心脏功能障碍患者的致命结局：一例病例报告
Int J Clin Pharmacol Ther. 2019 Dec;57(12):607-611. doi: 10.5414/CP203448.
5
Two Cases of Atezolizumab-Induced Hypophysitis.阿替利珠单抗诱发垂体炎两例
J Endocr Soc. 2017 Dec 13;2(1):91-95. doi: 10.1210/js.2017-00414. eCollection 2018 Jan 1.
6
Atezolizumab-Induced Stevens-Johnson Syndrome in a Patient with Non-Small Cell Lung Carcinoma.阿替利珠单抗诱发非小细胞肺癌患者发生史蒂文斯-约翰逊综合征
Case Rep Dermatol. 2018 Aug 9;10(2):198-202. doi: 10.1159/000492172. eCollection 2018 May-Aug.
7
Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer.OAK 研究中的患者报告结局：阿特珠单抗对比多西他赛用于晚期非小细胞肺癌的 III 期研究。
Clin Lung Cancer. 2018 Sep;19(5):441-449.e4. doi: 10.1016/j.cllc.2018.05.011. Epub 2018 May 31.
8
Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report.尼达尼布允许在因阿特珠单抗引起的肺炎后，对联合非小细胞肺癌/特发性肺纤维化用阿特珠单抗进行重新治疗：一例报告。
BMC Pulm Med. 2019 Aug 22;19(1):156. doi: 10.1186/s12890-019-0920-9.
9
Development of Halo Nevi in a Lung Cancer Patient: A Novel Immune-Related Cutaneous Event from Atezolizumab.一名肺癌患者出现晕痣：阿替利珠单抗引发的一种新型免疫相关皮肤事件。
J Drugs Dermatol. 2017 Oct 1;16(10):1047-1049.
10
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.阿特珠单抗联合或不联合 cobimetinib 对比regorafenib 治疗既往治疗的转移性结直肠癌（IMblaze370）：一项多中心、开放标签、3 期、随机、对照临床试验。
Lancet Oncol. 2019 Jun;20(6):849-861. doi: 10.1016/S1470-2045(19)30027-0. Epub 2019 Apr 16.
引用本文的文献
1
Clinical characteristics, diagnosis, treatment, and prognosis of Atezolizumab-induced encephalitis, aseptic meningitis or meningoencephalitis.阿替利珠单抗诱发的脑炎、无菌性脑膜炎或脑膜脑炎的临床特征、诊断、治疗及预后
Front Hum Neurosci. 2025 Jan 28;19:1443463. doi: 10.3389/fnhum.2025.1443463. eCollection 2025.
2
Patient with Atezolizumab-induced Encephalitis in Hepatocellular Carcinoma.肝细胞癌患者发生阿替利珠单抗诱导的脑炎。
Intern Med. 2025 Apr 15;64(8):1181-1187. doi: 10.2169/internalmedicine.4321-24. Epub 2024 Sep 11.
3
Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab.阿替利珠单抗诱导的伴有重叠性重症肌无力、心肌炎、血清阴性自身免疫性自主神经节神经病和肌炎症状的肝癌。
Intern Med. 2024 Aug 1;63(15):2193-2198. doi: 10.2169/internalmedicine.1801-23. Epub 2024 Jan 2.
4
Immune Checkpoint Inhibitor-Associated Striatal Encephalitis Presenting with Subacute Progressive Parkinsonism.免疫检查点抑制剂相关的纹状体脑炎伴亚急性进行性帕金森综合征
Mov Disord Clin Pract. 2023 Aug 24;10(Suppl 3):S7-S11. doi: 10.1002/mdc3.13800. eCollection 2023 Aug.
5
Long-term complete remission after severe pembrolizumab-induced immune-related encephalitis in metastatic lung adeno-squamous carcinoma: A case report.转移性肺腺鳞癌中帕博利珠单抗诱发的严重免疫相关性脑炎后的长期完全缓解：一例报告
Respir Med Case Rep. 2023 Jul 24;45:101898. doi: 10.1016/j.rmcr.2023.101898. eCollection 2023.
6
Atezolizumab-associated encephalitis in metastatic breast cancer: A case report.阿替利珠单抗相关的转移性乳腺癌脑炎：一例报告。
Oncol Lett. 2022 Jul 27;24(3):324. doi: 10.3892/ol.2022.13444. eCollection 2022 Sep.
7
Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review.阿替利珠单抗致肝癌患者脑炎：病例报告及文献复习。
Intern Med. 2022 Sep 1;61(17):2619-2623. doi: 10.2169/internalmedicine.8919-21. Epub 2022 Feb 19.
8
Pembrolizumab-Induced Meningoencephalitis: A Brain Autopsy Case.帕博利珠单抗诱导的脑膜脑炎：一例脑尸检病例
J Med Cases. 2021 Sep;12(9):359-365. doi: 10.14740/jmc3748. Epub 2021 Aug 25.
9
Case Report: Durvalumab-Associated Encephalitis in Extensive-Stage Small Cell Lung Carcinoma.病例报告：广泛期小细胞肺癌中与度伐利尤单抗相关的脑炎
Front Oncol. 2021 Jun 24;11:693279. doi: 10.3389/fonc.2021.693279. eCollection 2021.
10
Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors.一例转移性乳腺癌患者发生的阿替利珠单抗诱发的脑炎：病例报告及与检查点抑制剂相关的神经系统不良事件综述
Autops Case Rep. 2021 Apr 15;11:e2021261. doi: 10.4322/acr.2021.261.
本文引用的文献
1
Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature.重症监护病房中与阿替利珠单抗相关的脑炎：病例报告及文献综述
SAGE Open Med Case Rep. 2018 Aug 2;6:2050313X18792422. doi: 10.1177/2050313X18792422. eCollection 2018.
2
Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma.两例肺腺癌患者发生的纳武利尤单抗诱导的自身免疫性脑炎
Case Rep Neurol Med. 2018 Jul 4;2018:2548528. doi: 10.1155/2018/2548528. eCollection 2018.
3
A case of severe encephalitis while on PD-1 immunotherapy for recurrent clear cell ovarian cancer.一例复发性透明细胞卵巢癌患者在接受PD-1免疫治疗时发生严重脑炎。
Gynecol Oncol Rep. 2018 Mar 26;24:51-53. doi: 10.1016/j.gore.2018.03.007. eCollection 2018 May.
4
Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature.阿替利珠单抗诱发的转移性膀胱癌脑炎：一例报告及文献复习
Clin Genitourin Cancer. 2017 Oct;15(5):e847-e849. doi: 10.1016/j.clgc.2017.03.001. Epub 2017 Mar 16.
5
Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges.癌症治疗中的新型免疫检查点抑制抗体：机遇与挑战。
Drug Resist Updat. 2017 Jan;30:39-47. doi: 10.1016/j.drup.2017.02.001. Epub 2017 Feb 4.
6
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.阿特珠单抗对比多西他赛用于既往治疗过的非小细胞肺癌患者（OAK）：一项3期、开放标签、多中心随机对照试验
Lancet. 2017 Jan 21;389(10066):255-265. doi: 10.1016/S0140-6736(16)32517-X. Epub 2016 Dec 13.
7
The blockade of immune checkpoints in cancer immunotherapy.癌症免疫疗法中的免疫检查点阻断。
Nat Rev Cancer. 2012 Mar 22;12(4):252-64. doi: 10.1038/nrc3239.
Zotero 插件